| 1. |
- Aad, G., et al.
(författare)
-
- 2013
-
Tidskriftsartikel (refereegranskat)
|
|
| 2. |
- Aad, G., et al.
(författare)
-
- 2012
-
Ingår i: Journal of High Energy Physics. - 1029-8479 .- 1126-6708. ; :11
-
Tidskriftsartikel (refereegranskat)
|
|
| 3. |
- Aad, G., et al.
(författare)
-
- 2013
-
Ingår i: Journal of Instrumentation. - 1748-0221. ; 8
-
Tidskriftsartikel (refereegranskat)
|
|
| 4. |
- Aad, G., et al.
(författare)
-
- 2012
-
Tidskriftsartikel (refereegranskat)
|
|
| 5. |
- Aad, G., et al.
(författare)
-
- 2013
-
Tidskriftsartikel (refereegranskat)
|
|
| 6. |
- Aad, G., et al.
(författare)
-
- 2012
-
swepub:Mat__t (refereegranskat)
|
|
| 7. |
- Aad, G., et al.
(författare)
-
- 2012
-
swepub:Mat__t (refereegranskat)
|
|
| 8. |
- Aad, G., et al.
(författare)
-
- 2014
-
Tidskriftsartikel (refereegranskat)
|
|
| 9. |
- Klionsky, Daniel J., et al.
(författare)
-
Guidelines for the use and interpretation of assays for monitoring autophagy
- 2012
-
Ingår i: Autophagy. - : Informa UK Limited. - 1554-8635 .- 1554-8627. ; 8:4, s. 445-544
-
Forskningsöversikt (refereegranskat)abstract
- In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. A key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process vs. those that measure flux through the autophagy pathway (i.e., the complete process); thus, a block in macroautophagy that results in autophagosome accumulation needs to be differentiated from stimuli that result in increased autophagic activity, defined as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (in most higher eukaryotes and some protists such as Dictyostelium) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the field understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field.
|
|
| 10. |
- Eng, Mattias P, 1977, et al.
(författare)
-
Concentration-Dependent Hole Mobility and Recombination Coefficient in Bulk Heterojunctions Determined from Transient Absorption Spectroscopy
- 2010
-
Ingår i: Journal of Physical Chemistry Letters. - : American Chemical Society (ACS). - 1948-7185. ; 1:20, s. 3096-3100
-
Tidskriftsartikel (refereegranskat)abstract
- A simple analytical function based on the multiple trapping model, is used to describe the biomolecular recombination of charge carriers in a bulk heterojunction (BHJ) film in the presence of an exponential energetic tail of localized hole "trap" states. The function is used to fit charge carrier decay data from an unannealed P3HT/PCBM film measured by transient absorption. The analysis assumes that only free holes participate in recombination and transport. This implies an effective recombination rate coefficient which varies with the ratio of free to trapped holes. The fit parameters yield a bimolecular recombination constant for free holes with free electrons (k(o) = 3.4 x 10(-12) cm(3) s(-1)) and information about the distribution of trap states (trap distribution parameter beta = 0.29) Assuming the Langevin recombination limit, the analysis yields a concentration dependent effective hole mobility saturating at mu(o) approximate to 7 x 10(-2) cm(2) V-1 s(-1). This approach should be useful to compare BHJs in a consistent and meaningful manner.
|
|
| 11. |
- Sharma, Manu, et al.
(författare)
-
Large-scale replication and heterogeneity in Parkinson disease genetic loci
- 2012
-
Ingår i: Neurology. - 1526-632X. ; 79:7, s. 67-659
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: Eleven genetic loci have reached genome-wide significance in a recent meta-analysis of genome-wide association studies in Parkinson disease (PD) based on populations of Caucasian descent. The extent to which these genetic effects are consistent across different populations is unknown.METHODS: Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium were invited to participate in the study. A total of 11 SNPs were genotyped in 8,750 cases and 8,955 controls. Fixed as well as random effects models were used to provide the summary risk estimates for these variants. We evaluated between-study heterogeneity and heterogeneity between populations of different ancestry.RESULTS: In the overall analysis, single nucleotide polymorphisms (SNPs) in 9 loci showed significant associations with protective per-allele odds ratios of 0.78-0.87 (LAMP3, BST1, and MAPT) and susceptibility per-allele odds ratios of 1.14-1.43 (STK39, GAK, SNCA, LRRK2, SYT11, and HIP1R). For 5 of the 9 replicated SNPs there was nominally significant between-site heterogeneity in the effect sizes (I(2) estimates ranged from 39% to 48%). Subgroup analysis by ethnicity showed significantly stronger effects for the BST1 (rs11724635) in Asian vs Caucasian populations and similar effects for SNCA, LRRK2, LAMP3, HIP1R, and STK39 in Asian and Caucasian populations, while MAPT rs2942168 and SYT11 rs34372695 were monomorphic in the Asian population, highlighting the role of population-specific heterogeneity in PD.CONCLUSION: Our study allows insight to understand the distribution of newly identified genetic factors contributing to PD and shows that large-scale evaluation in diverse populations is important to understand the role of population-specific heterogeneity.
|
|
| 12. |
|
|
| 13. |
- Andreasson, Joakim, 1973, et al.
(författare)
-
A dihydroindolizine-porphyrin dyad as molecule-based all-photonic AND and NAND gates
- 2011
-
Ingår i: Dyes and Pigments. - : Elsevier BV. - 0143-7208 .- 1873-3743. ; 89:3, s. 284-289
-
Tidskriftsartikel (refereegranskat)abstract
- A molecular dyad consisting of a photochromic dihydroindolizine unit covalently linked to a porphyrin performs, when illuminated through a third-harmonic-generating crystal, the functions of both an AND and a NAND Boolean logic gate with shared all-optical inputs. The NAND gate is of particular interest as it is a so-called universal gate, and hence all other digital systems can be implemented by combinations of NAND gates. The functions of the AND and the NAND gates rely on changes in absorption and emission of the dyad in the visible spectral region upon isomerization of the photochromic unit. The change in absorption which forms the basis for the AND gate function is ascribed to the colorization/decolorization of the photochrome itself in response to the optical inputs. The variation in emission intensity which constitutes the NAND gate function is a result of the changes in redox properties of the photochrome that follow upon isomerization, such that only one of the two isomers is competent to quench the porphyrin emission by electron transfer.
|
|
| 14. |
- Eng, Mattias P, 1977, et al.
(författare)
-
Impact of concentration self-quenching on the charge generation yield of fullerene based donor-bridge-acceptor compounds in the solid state
- 2011
-
Ingår i: Physical Chemistry Chemical Physics. - : Royal Society of Chemistry (RSC). - 1463-9084 .- 1463-9076. ; 13:9, s. 3721-3729
-
Tidskriftsartikel (refereegranskat)abstract
- A fullerene based Donor-Bridge-Acceptor (DBA) compound, incorporating a pi-extended tetrathiafulvalene electron donor, is investigated with respect to its photophysics in solution versus solid state. Solid films of neat DBA are compared with blend films where the DBA compound is diluted in the inert, low dielectric, polymer poly(styrene). It is found that the moderate intermolecular electronic coupling and donor-acceptor separation (22 angstrom) in this case leads to the generation of more dissociated, intermolecular charges than a mixture of the donor and acceptor reference compounds. However, the increased intermolecular interactions in the solid state lead to the excited state of the fullerene suffering from concentration self-quenching. This is found to severely affect the charge generation yield in solid films. The impact of competing intra and intermolecular interactions in the solid state upon the film photophysics is analysed in terms of a kinetic model which includes both the effects of concentration self-quenching and the impact of film composition upon the dielectric stabilisation of charge separated states. We conclude that both concentration self-quenching and dielectric stabilisation are critical in determining the photophysics of the blend films, and discuss strategies based upon our observations to enhance the charge photogeneration properties of organic films and photovoltaic devices based upon DBA compounds.
|
|
| 15. |
- Evangelou, Evangelos, et al.
(författare)
-
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease : large-scale collaborative study
- 2010
-
Ingår i: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. - : Wiley. - 1552-4841 .- 1552-485X. ; 153B:1, s. 8-220
-
Tidskriftsartikel (refereegranskat)abstract
- Early genome-wide association (GWA) studies on Parkinson's disease (PD) have not been able to yield conclusive, replicable signals of association, perhaps due to limited sample size. We aimed to investigate whether association signals derived from the meta-analysis of the first two GWA investigations might be replicable in different populations. We examined six single-nucleotide polymorphisms (SNPs) (rs1000291, rs1865997, rs2241743, rs2282048, rs2313982, and rs3018626) that had reached nominal significance with at least two of three different strategies proposed in a previous analysis of the original GWA studies. Investigators from the "Genetic Epidemiology of Parkinson's Disease" (GEOPD) consortium were invited to join in this study. Ten teams contributed replication data from 3,458 PD cases and 3,719 controls. The data from the two previously published GWAs (599 PD cases, 592 controls and 443 sibling pairs) were considered as well. All data were synthesized using both fixed and random effects models. The summary allelic odds ratios were ranging from 0.97 to 1.09 by random effects, when all data were included. The summary estimates of the replication data sets (excluding the original GWA data) were very close to 1.00 (range 0.98-1.09) and none of the effects were nominally statistically significant. The replication data sets had significantly different results than the GWA data. Our data do not support evidence that any of these six SNPs reflect susceptibility markers for PD. Much stronger signals of statistical significance in GWA platforms are needed to have substantial chances of replication. Specifically in PD genetics, this would require much larger GWA studies and perhaps novel analytical techniques.
|
|
| 16. |
- Hachinski, Vladimir, et al.
(författare)
-
Stroke: Working Toward a Prioritized World Agenda
- 2010
-
Ingår i: Stroke: a journal of cerebral circulation. - 1524-4628. ; 41:6, s. 1084-1099
-
Tidskriftsartikel (refereegranskat)abstract
- Background and Purpose-The aim of the Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke. Methods-Preliminary work was performed by 7 working groups of stroke leaders followed by a synergium (a forum for working synergistically together) with approximately 100 additional participants. The resulting draft document had further input from contributors outside the synergium. Results-Recommendations of the Synergium are: Basic Science, Drug Development and Technology: There is a need to develop: (1) New systems of working together to break down the prevalent "silo" mentality; (2) New models of vertically integrated basic, clinical, and epidemiological disciplines; and (3) Efficient methods of identifying other relevant areas of science. Stroke Prevention: (1) Establish a global chronic disease prevention initiative with stroke as a major focus. (2) Recognize not only abrupt clinical stroke, but subtle subclinical stroke, the commonest type of cerebrovascular disease, leading to impairments of executive function. (3) Develop, implement and evaluate a population approach for stroke prevention. (4) Develop public health communication strategies using traditional and novel (eg, social media/marketing) techniques. Acute Stroke Management: Continue the establishment of stroke centers, stroke units, regional systems of emergency stroke care and telestroke networks. Brain Recovery and Rehabilitation: (1) Translate best neuroscience, including animal and human studies, into poststroke recovery research and clinical care. (2) Standardize poststroke rehabilitation based on best evidence. (3) Develop consensus on, then implementation of, standardized clinical and surrogate assessments. (4) Carry out rigorous clinical research to advance stroke recovery. Into the 21st Century: Web, Technology and Communications: (1) Work toward global unrestricted access to stroke-related information. (2) Build centralized electronic archives and registries. Foster Cooperation Among Stakeholders (large stroke organizations, nongovernmental organizations, governments, patient organizations and industry) to enhance stroke care. Educate and energize professionals, patients, the public and policy makers by using a "Brain Health" concept that enables promotion of preventive measures. Conclusions-To accelerate progress in stroke, we must reach beyond the current status scientifically, conceptually, and pragmatically. Advances can be made not only by doing, but ceasing to do. Significant savings in time, money, and effort could result from discontinuing practices driven by unsubstantiated opinion, unproven approaches, and financial gain. Systematic integration of knowledge into programs coupled with careful evaluation can speed the pace of progress.
|
|
| 17. |
- Hachinski, Vladimir, et al.
(författare)
-
Stroke: Working toward a Prioritized World Agenda
- 2010
-
Ingår i: Cerebrovascular Diseases. - : S. Karger AG. - 1421-9786 .- 1015-9770. ; 30:2, s. 127-147
-
Tidskriftsartikel (refereegranskat)abstract
- Background and Purpose: The aim of the Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke. Methods: Preliminary work was performed by 7 working groups of stroke leaders followed by a synergium (a forum for working synergistically together) with approximately 100 additional participants. The resulting draft document had further input from contributors outside the synergium. Results: Recommendations of the Synergium are: Basic Science, Drug Development and Technology: There is a need to develop: (1) New systems of working together to break down the prevalent 'silo' mentality; (2) New models of vertically integrated basic, clinical, and epidemiological disciplines; and (3) Efficient methods of identifying other relevant areas of science. Stroke Prevention: (1) Establish a global chronic disease prevention initiative with stroke as a major focus. (2) Recognize not only abrupt clinical stroke, but subtle subclinical stroke, the commonest type of cerebrovascular disease, leading to impairments of executive function. (3) Develop, implement and evaluate a population approach for stroke prevention. (4) Develop public health communication strategies using traditional and novel (e. g., social media/marketing) techniques. Acute Stroke Management: Continue the establishment of stroke centers, stroke units, regional systems of emergency stroke care and telestroke networks. Brain Recovery and Rehabilitation: (1) Translate best neuroscience, including animal and human studies, into poststroke recovery research and clinical care. (2) Standardize poststroke rehabilitation based on best evidence. (3) Develop consensus on, then implementation of, standardized clinical and surrogate assessments. (4) Carry out rigorous clinical research to advance stroke recovery. Into the 21st Century: Web, Technology and Communications: (1) Work toward global unrestricted access to stroke-related information. (2) Build centralized electronic archives and registries. Foster Cooperation Among Stakeholders (large stroke organizations, nongovernmental organizations, governments, patient organizations and industry) to enhance stroke care. Educate and energize professionals, patients, the public and policy makers by using a 'Brain Health' concept that enables promotion of preventive measures. Conclusions: To accelerate progress in stroke, we must reach beyond the current status scientifically, conceptually, and pragmatically. Advances can be made not only by doing, but ceasing to do. Significant savings in time, money, and effort could result from discontinuing practices driven by unsubstantiated opinion, unproven approaches, and financial gain. Systematic integration of knowledge into programs coupled with careful evaluation can speed the pace of progress. Copyright (C) 2010 American Heart Association. Inc., S. Karger AG, Basel, and John Wiley & Sons, Inc.
|
|
| 18. |
- Hachinski, Vladimir, et al.
(författare)
-
Stroke: working toward a prioritized world agenda
- 2010
-
Ingår i: International Journal of Stroke. - : SAGE Publications. - 1747-4949 .- 1747-4930. ; 5:4, s. 238-256
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Background and Purpose The aim of the Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke. Methods Preliminary work was performed by seven working groups of stroke leaders followed by a synergium (a forum for working synergistically together) with approximately 100 additional participants. The resulting draft document had further input from contributors outside the synergium. Results Recommendations of the Synergium are: Basic Science, Drug Development and Technology: There is a need to develop: (1) New systems of working together to break down the prevalent 'silo' mentality; (2) New models of vertically integrated basic, clinical, and epidemiological disciplines; and (3) Efficient methods of identifying other relevant areas of science. Stroke Prevention: (1) Establish a global chronic disease prevention initiative with stroke as a major focus. (2) Recognize not only abrupt clinical stroke, but subtle subclinical stroke, the commonest type of cerebrovascular disease, leading to impairments of executive function. (3) Develop, implement and evaluate a population approach for stroke prevention. (4) Develop public health communication strategies using traditional and novel (eg, social media/marketing) techniques. Acute Stroke Management: Continue the establishment of stroke centers, stroke units, regional systems of emergency stroke care and telestroke networks. Brain Recovery and Rehabilitation: (1) Translate best neuroscience, including animal and human studies, into poststroke recovery research and clinical care. (2) Standardize poststroke rehabilitation based on best evidence. (3) Develop consensus on, then implementation of, standardized clinical and surrogate assessments. (4) Carry out rigorous clinical research to advance stroke recovery. Into the 21st Century: Web, Technology and Communications: (1) Work toward global unrestricted access to stroke-related information. (2) Build centralized electronic archives and registries. Foster Cooperation Among Stakeholders (large stroke organizations, nongovernmental organizations, governments, patient organizations and industry) to enhance stroke care. Educate and energize professionals, patients, the public and policy makers by using a 'Brain Health' concept that enables promotion of preventive measures. Conclusions To accelerate progress in stroke, we must reach beyond the current status scientifically, conceptually, and pragmatically. Advances can be made not only by doing, but ceasing to do. Significant savings in time, money, and effort could result from discontinuing practices driven by unsubstantiated opinion, unproven approaches, and financial gain. Systematic integration of knowledge into programs coupled with careful evaluation can speed the pace of progress.
|
|
| 19. |
- Hernandez, M., et al.
(författare)
-
Modeling of VOC mass transfer in two-liquid phase stirred tank, biotrickling filter and airlift reactors
- 2011
-
Ingår i: Chemical Engineering Journal. - : Elsevier BV. - 1385-8947. ; 172:2-3, s. 961-969
-
Tidskriftsartikel (refereegranskat)abstract
- A modeling framework based on general mass balances and transfer equations was here developed in order to compare the hexane mass transfer performance of two-liquid phase stirred tank reactor (SIR), airlift (ALR) and biotrickling filter (BTF) using silicone oil as model non-aqueous phase under abiotic conditions. This modeling approach resulted in an isomorphous expression for all configurations consisting of a parameter beta*(s) (characterizing the maximum fraction of VOC transferable from the gas to the aqueous phase) and the gradient established between the gas and the aqueous phase. The models were validated against experimental data (at empty bed residence times, EBRT, of 120, 60 and 40 s) exhibiting an overall goodness of fit of 0.98, 0.98 and 0.70 for the two-liquid phase STR, BTF and ALR, respectively. The two-liquid phase BTF exhibited the maximum value of beta*(s) (0.87-0.58), followed by the STR (0.77-0.49) and the ALR (0.23-0.19). Finally, a sensitivity analysis conducted in the two-liquid phase BTF showed that was more sensitive to changes in recirculating liquid flow rate than in the EBRT, confirming that the liquid flow rate is a key operational variable in BTF systems.
|
|
| 20. |
- Johansson, Johan, 1980, et al.
(författare)
-
Bridging Ligand Length Controls AT Selectivity and Enantioselectivity of Binuclear Ruthenium Threading Intercalators
- 2013
-
Ingår i: Chemistry-a European Journal. - : Wiley. - 0947-6539 .- 1521-3765. ; 19:20, s. 6246-6256
-
Tidskriftsartikel (refereegranskat)abstract
- The slow dissociation of DNA threading intercalators makes them interesting as model compounds in the search for new DNA targeting drugs, as there appears to be a correlation between slow dissociation and biological activity. Thus, it would be of great value to understand the mechanisms controlling threading intercalation, and for this purpose we have investigated how the length of the bridging ligand of binuclear ruthenium threading intercalators affects their DNA binding properties. We have synthesised a new binuclear ruthenium threading intercalator with slower dissociation kinetics from ct-DNA than has ever been observed for any ruthenium complex with any type of DNA, a property that we attribute to the increased distance between the ruthenium centres of the new complex. By comparison with previously studied ruthenium complexes, we further conclude that elongation of the bridging ligand reduces the sensitivity of the threading interaction to DNA flexibility, resulting in a decreased AT selectivity for the new complex. We also find that the length of the bridging ligand affects the enantioselectivity with increasing preference for the enantiomer as the bridging ligand becomes longer.
|
|
| 21. |
- Krüger, Rejko, et al.
(författare)
-
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
- 2011
-
Ingår i: Neurobiology of Aging. - : Elsevier BV. - 1558-1497 .- 0197-4580. ; 32:3, s. 9-548
-
Tidskriftsartikel (refereegranskat)abstract
- High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common Omi/HtrA2 variants in the Genetic Epidemiology of Parkinson's disease (GEO-PD) consortium. GEO-PD sites provided clinical and genetic data including affection status, gender, ethnicity, age at study, age at examination (all subjects); age at onset and family history of PD (patients). Genotyping was performed for the five most informative SNPs spanning the Omi/HtrA2 gene in approximately 2-3 kb intervals (rs10779958, rs2231250, rs72470544, rs1183739, rs2241028). Fixed as well as random effect models were used to provide summary risk estimates of Omi/HtrA2 variants. The 20 GEO-PD sites provided data for 6378 cases and 8880 controls. No overall significant associations for the five Omi/HtrA2 SNPs and PD were observed using either fixed effect or random effect models. The summary odds ratios ranged between 0.98 and 1.08 and the estimates of between-study heterogeneity were not large (non-significant Q statistics for all 5 SNPs; I(2) estimates 0-28%). Trends for association were seen for participants of Scandinavian descent for rs2241028 (OR 1.41, p=0.04) and for rs1183739 for age at examination (cut-off 65 years; OR 1.17, p=0.02), but these would not be significant after adjusting for multiple comparisons and their Bayes factors were only modest. This largest association study performed to define the role of any gene in the pathogenesis of Parkinson's disease revealed no overall strong association of Omi/HtrA2 variants with PD in populations worldwide.
|
|
| 22. |
- Shoaee, Safa, et al.
(författare)
-
Influence of nanoscale phase separation on geminate versus bimolecular recombination in P3HT:fullerene blend films
- 2010
-
Ingår i: Energy and Environmental Sciences. - 1754-5692 .- 1754-5706. ; 7:3, s. 971-976
-
Tidskriftsartikel (refereegranskat)abstract
- In this paper, we compare the charge recombination dynamics observed in films comprising poly(3-hexylthiophene) blended with three fullerene derivatives: PCBM and two alternative pyrazolinofullerenes. Transient absorption data indicate that replacement of PCBM with either of the pyrazolinofullerene derivatives results in a transition from bimolecular to monomolecular (geminate) recombination dynamics. We show that this transition cannot be explained by a difference in interfacial energetics. However, this transition does correlate with nanomorphology data which indicate that both pyrazolinofullerenes yield a much finer phase segregation, with correspondingly smaller domain sizes, than observed with PCBM. Our results therefore provide clear evidence of the role of nanomorphology in determining the nature of recombination dynamics in such donor/acceptor blends.
|
|
